TaiRx US, Inc.
  • HOME
  • TEAM
  • RESEARCH
  • CONTACT US

HOME


TaiRx US, Inc. is an R&D based pharmaceutical company committed to developing novel therapeutics and precision medicine diagnostics for cancer treatment.

TaiRx US, Inc. is a subsidiary of TaiRx, Inc., a publicly-traded pharmaceutical company headquartered in Taipei, Taiwan.

TaiRx US, Inc. is an independent, Delaware C-Corp that has exclusive, worldwide rights to the patent estate on Nodal established by Mary J. C. Hendrix, Ph.D., former President of the Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago and Northwestern University’s Feinberg School of Medicine, and former President of Shepherd University, who led the research delineating the critical role Nodal plays in cancer. Nodal, a secreted growth-promoting protein that is normally and predominantly expressed in the embryo — was discovered to be re-expressed in cancer cells during progression and metastasis and associated with resistance to known therapies.

Our team has extensive experience and knowledge in new drug development. This allows us to expedite the drug development process of our identified drug candidates going from early development to regulatory IND/NDA approval.

    Copyright 2026 © TaiRx US, Inc.

    Privacy Policy

    We use cookies to improve your user experience and for web traffic statistics purposes. Privacy Policy.

    功能性 一律啟用
    技術性儲存或存取,若為啟用訂閱者或使用者明確要求之特定服務的正當目的,或純粹為了在電子通訊網路上傳輸通訊,則是嚴格必要的。
    偏好設定
    技術性儲存或存取是為了儲存訂閱者或使用者未要求的偏好設定之合法目的所必要。
    統計資料
    僅用於統計目的的技術性儲存或存取。 僅用於匿名統計目的的技術性儲存或存取。除非取得傳票、網際網路服務提供者自願配合,或第三方提供其他紀錄,否則僅為此目的儲存或擷取的資訊通常無法用來識別您。
    行銷
    若要建立使用者個人檔案以傳送廣告,或在網站或多個網站上追蹤使用者以達到類似的行銷目的,就需要技術性儲存或存取。
    • 管理選項
    • 管理服務
    • 管理 {vendor_count} 個供應商
    • 閱讀更多關於這些目的的資訊
    檢視偏好設定
    • {title}
    • {title}
    • {title}